Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 977,700 | 906,600 | 943,700 | 894,800 | 888,500 |
| Cost of Goods | 234,700 | 224,900 | 246,200 | 233,600 | 235,300 |
| Gross Profit | 743,000 | 681,700 | 697,500 | 661,200 | 653,200 |
| Operating Expenses | 749,000 | 433,700 | 445,600 | 409,300 | 349,000 |
| Operating Income | -5,300 | 248,900 | 252,100 | 252,500 | 304,500 |
| Interest Expense | 29,400 | 500 | 0 | 0 | 19,300 |
| Other Income | 32,900 | 300 | -1,100 | 11,000 | 38,700 |
| Pre-tax Income | -1,800 | 248,700 | 251,000 | 263,500 | 323,900 |
| Income Tax | -8,800 | 22,800 | -31,700 | 56,900 | 326,700 |
| Net Income Continuous | 7,000 | 225,900 | 282,700 | 206,600 | -2,800 |
| Net Income | $7,000 | $225,900 | $282,700 | $206,600 | $-2,800 |
| EPS Basic Total Ops | 0.01 | 0.36 | 0.45 | 0.33 | 0.00 |
| EPS Basic Continuous Ops | 0.01 | 0.36 | 0.45 | 0.33 | 0.00 |
| EPS Diluted Total Ops | 0.02 | 0.35 | 0.44 | 0.32 | 0.00 |
| EPS Diluted Continuous Ops | 0.01 | 0.35 | 0.44 | 0.32 | 0.00 |
| EBITDA(a) | $14,600 | $268,100 | $271,300 | $271,600 | $325,700 |